Open enrollment for Medicare Advantage (MA) plans is now in progress, and before selecting or renewing your current plan, The Senior Citizens League (TSCL) encourages all members and supporters to explore their options diligently. According to the Congressional Budget Office, more than 0 billion will be cut from the program by 2023 due to requirements under the Affordable Care Act (ACA), and many MA plans may be making modifications to benefit packages and provider networks that could affect enrollees significantly. .If signed into law, the Medicare Physician Payment Innovation Act would repeal the sustainable growth rate (SGR) formula for physician reimbursements, and it would set up a five-year trial period during which the Centers for Medicare and Medicaid Services would test and evaluate new payment and delivery models. TSCL strongly believes that the SGR formula breeds uncertainty in the Medicare program for both physicians and beneficiaries. Many doctors have stopped accepting Medicare patients, and many more are threatening to do so if a permanent solution is not established soon. We believe that Rep. Schwartz's bill would bring increased stability to the Medicare program, and we were pleased to see four new cosponsors announce their support for it this week. .— who have no Medicare supplement through a former employer. .As a proud affiliate of TREThe Enlisted Association, and because many of TSCL supporters are military retirees we keep a close eye on the health benefits of military retirees. .Senate Majority Leader Mitch McConnell (R-Ky.) has indicated he will not bring the bill up for a vote until he knows there are enough Republicans who support it so that it can pass. .'It´s not clear why the administration hasn't made a bigger push to line up votes to get a bill through the Senate and a deal with Congress, given strong public support to lower drug costs,' said Tricia Neuman, a Medicare expert with the nonpartisan Kaiser Family Foundation. .The total cost for a single year of treatment with the nation's most expensive specialty drugs can cost more than the entire retirement savings for many retirees. The annual cost of the cancer drug Idhifa, for example, is 0,85According to a new study by the non-partisan Kaiser Family Foundation, the median out-of-pocket cost that Medicare Part D beneficiaries will pay out-of-pocket for specialty drugs in 2019 would be ,55Patients suffering from multiple sclerosis could pay an estimated out-of-pocket of ,409 in 2019 for Glatiramer acetate. Even on the "low side," the annual out-of-pocket for Hepatitis C drug, Zepatier runs ,622. .Sources: "Appeals Panel Weighs Fate of Obama's Immigration Overhaul," Michael Shear, The New York Times, April 17, 201"Effects Of Unauthorized Immigration On The Actuarial Status Of The Social Security Trust Funds," Actuarial Note 151, Social Security Administration, April 2013. .TSCL supports H.R. 973 and H.R. 1391 since both would modernize the Social Security program in a responsible way. We were pleased to see them gain critical support this week.